However, the specific role of EpCAM itself in early-stage hepatocellular carcinoma progression remains unclear, and small molecules targeting EpCAM have not yet been reported. Molecular docking ...
Finally, PD-L1, CD155, CD111, and various immune subsets have been reported by preclinical studies as potential biomarkers, and further research is necessary to explore other potential molecular and ...
Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.
were applied to analyze ANKRD27 expression in multiple cancer types and its correlations with immune scores, immune checkpoint genes, and immune modulatory genes. We also examined ANKRD27 expression ...
1 College of Life Sciences, Joint Institute of Nanjing Drum Tower Hospital for Life and Health, Nanjing Normal University, Nanjing, China 2 Department of Hematology, Nanjing Drum Tower Hospital ...
2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. 3Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, ...
1Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2Department of Surgery, Keio ...
Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...
Skin cancer is by far the most common type of cancer in the United States. Merkel cell carcinoma (MCC) is a type of skin cancer, but it's not common. About 3,000 people are diagnosed with Merkel cell ...